Caplin-Point-Laboratories-Ltd Stock/Share Prices, Buy and Sell Caplin-Point-Laboratories-Ltd BSE Stocks

Market Snapshot

BSE Sensex: 40292.64 0.37%
BSE 500: 15377.41 0.31%
BSE 200: 4963.79 0.34%
BSE 100: 11874.07 0.39%
BSE Mid-Cap: 14771.14 0.41%
BSE Small-Cap: 15000.27 -0.00%
BANKEX: 27861.49 1.64%
BSE IT Sector: 21472.64 -0.49%
Nifty 50: 11795 0.23%
Nifty 500: 9664.7 0.18%
Nifty 200: 6071.05 0.21%
Nifty 100: 11872 0.25%
Nifty Midcap 100: 17002.3 -0.04%
Nifty Small 100: 5904 -0.48%
Nifty IT: 21215.35 -0.24%
Nifty PSU Bank: 1287.5 -1.27%

News:

Godrej Properties Ltd Falls 2....
Adani Green Energy Ltd Surges ...
IDBI Bank board to mull fund r...
NTPC to consider share buyback...
SBI Life advances after strong...

Caplin Point Laboratories Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

27 Oct 2020 | 09:48 AM

520.55

-3.65 (-0.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

37.57%

Return (1Y)

Underperformed S&P BSE Healthcare by 11.6%
More Volatile

4.26%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.6%
Not so consistent

5/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

686

180

News & Announcements

Caplin Point Laboratories to conduct AGM
77 days ago

Caplin Point Laboratories to conduct AGM

10 - Aug - 2020 12:00 AM | 77 days ago

Caplin Point Laboratories announced that the 29th Annual General Meeting (AGM) of the company will be held on 28 September 2020.
Powered by Capital Market - Live News
Caplin Point Laboratories consolidated net profit rises 8.56% in the June 2020 quarter
77 days ago

Caplin Point Laboratories consolidated net profit rises 8.56% in the June 2020 quarter

10 - Aug - 2020 12:00 AM | 77 days ago

Net profit of Caplin Point Laboratories rose 8.56% to Rs 54.53 crore in the quarter ended June 2020 as against Rs 50.23 crore during the previous quarter ended June 2019. Sales rose 24.68% to Rs 240.08 crore in the quarter ended June 2020 as against Rs 192.55 crore during the previous quarter ended June 2019.
Particulars Quarter Ended
Jun. 2020 Jun. 2019 % Var.
Sales 240.08 192.55 25
OPM % 29.82 34.99 -
PBDT 77.58 71.84 8
PBT 68.62 64.45 6
NP 54.53 50.23 9
Powered by Capital Market - Live News
Caplin Point Laboratories standalone net profit declines 30.08% in the June 2020 quarter
77 days ago

Caplin Point Laboratories standalone net profit declines 30.08% in the June 2020 quarter

10 - Aug - 2020 12:00 AM | 77 days ago

Net profit of Caplin Point Laboratories declined 30.08% to Rs 42.02 crore in the quarter ended June 2020 as against Rs 60.10 crore during the previous quarter ended June 2019. Sales declined 14.64% to Rs 119.73 crore in the quarter ended June 2020 as against Rs 140.27 crore during the previous quarter ended June 2019.
Particulars Quarter Ended
Jun. 2020 Jun. 2019 % Var.
Sales 119.73 140.27 -15
OPM % 47.98 41.68 -
PBDT 61.45 78.39 -22
PBT 56.02 74.03 -24
NP 42.02 60.10 -30
Powered by Capital Market - Live News
Caplin Point Laboratories to announce Quarterly Result
84 days ago

Caplin Point Laboratories to announce Quarterly Result

03 - Aug - 2020 12:00 AM | 84 days ago

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on 10 August 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Caplin Point Laboratories Ltd has decreased by -27.04% since past 3 Months
MF shareholding in Caplin Point Laboratories Ltd has increased by 8383.78% since past 3 Months
FII shareholding in Caplin Point Laboratories Ltd has decreased by -71.09% since past 1 Year
MF shareholding in Caplin Point Laboratories Ltd has increased by 22321.4% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2020	Jun. 2019	% Var.
Sales	240.08	192.55	25
OPM %	29.82	34.99	-
PBDT	77.58	71.84	8
PBT	68.62	64.45	6
NP	54.53	50.23	9

Particulars	Quarter Ended
	Jun. 2020	Jun. 2019	% Var.
Sales	119.73	140.27	-15
OPM %	47.98	41.68	-
PBDT	61.45	78.39	-22
PBT	56.02	74.03	-24
NP	42.02	60.10	-30

General Notifications

My Notifications

Research Notifications

Caplin Point Laboratories Ltd NSE / BSE Pharmaceuticals, Small Cap

520.55 -3.65 (-0.70%)

News & Announcements

Price vs Volume

Stock Trivia

Caplin Point Laboratories Ltd NSE / BSE
Pharmaceuticals, Small Cap

520.55

-3.65 (-0.70%)